SS
ALNY icon

Simplicity Solutions’s Alnylam Pharmaceuticals ALNY Stock Holding History

Simplicity Solutions’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$382K Buy
1,997
+375
+23% +$63.9K 0.01% 753
2023
Q3 		$287K Sell
1,622
-225
-12% -$42.9K 0.01% 785
2023
Q2 		$351K Buy
1,847
+138
+8% +$27.4K 0.01% 776
2023
Q1 		$342K Buy
1,709
+559
+49% +$118K 0.01% 805
2022
Q4 		$273K Buy
+1,150
New +$245K 0.04% 511

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Simplicity Solutions's ALNY Position: Q4 2023 in Review

Simplicity Solutions increased its Alnylam Pharmaceuticals (ALNY) stake by 23% in Q4 2023, buying an estimated $63.9K and bringing the position to 1,997 shares worth $382K. The position accounts for 0.01% of the portfolio, ranked #753.

Simplicity Solutions first reported a position in ALNY in Q4 2022 and has held it in 5 quarters since. 498 funds tracked by Wall St. Rank hold ALNY as of Q4 2023.

  • Simplicity Solutions held 1,997 shares of Alnylam Pharmaceuticals worth $382K as of Q4 2023.
  • Simplicity Solutions bought 375 Alnylam Pharmaceuticals shares in Q4 2023, an estimated $63.9K.
  • Alnylam Pharmaceuticals made up 0.01% of Simplicity Solutions's portfolio in Q4 2023, its #753 holding.
  • Simplicity Solutions first reported a position in Alnylam Pharmaceuticals in Q4 2022 and has held it in 5 quarters since.
  • 498 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.